Ads
related to: acea therapeutics
Search results
Sorrento (SRNE) Up on Positive Result From Lung Cancer Study
Zacks via Yahoo Finance· 2 years agoSorrento Therapeutics SRNE moved up 6.21% in August, during market hours, after the drugmaker...
What Kind Of Investors Own Most Of Sorrento Therapeutics, Inc. (NASDAQ:SRNE)?
Simply Wall St. via Yahoo Finance· 2 years agoThe big shareholder groups in Sorrento Therapeutics, Inc. (NASDAQ:SRNE) have power over the company....
Bankrupt Sorrento Therapeutics Secures Court Approval for $75M Financing
Benzinga via Yahoo Finance· 1 year agoSorrento Therapeutics Inc (NASDAQ: SRNE) announced that the U.S. Bankruptcy Court for the Southern...
Sorrento Shares Pop After Interim Data From Lung Cancer Trial
Benzinga via Yahoo Finance· 2 years agoSorrento Therapeutics Inc (NASDAQ: SRNE) announced positive results from a pivotal study of...
Sorrento Touts Positive Early-Stage Trial Data From Oral COVID-19 Therapy
Benzinga via Yahoo Finance· 1 year agoSorrento Therapeutics Inc (NASDAQ: SRNE) released topline Phase 2 SAD/MAD study data of its oral...
FDA Clears Sorrento's STI-1558 Phase 1 Study To Treat COVID-19 Infection
Benzinga via Yahoo Finance· 2 years agoThe FDA has signed off Sorrento Therapeutics Inc's (NASDAQ: SRNE) Phase 1 study of its oral main...
Sorrento Has Potential To Deliver Multiple Best-In-Class Products
Benzinga via Yahoo Finance· 2 years agoCantor Fitzgerald initiated coverage on Sorrento Therapeutics Inc (NASDAQ: SRNE) with an Overweight...
Sorrento Therapeutics Stock Nosedives After Filing Bankruptcy Paperwork
Benzinga via Yahoo Finance· 1 year agoCOVID-19 drug and vaccine developer Sorrento Therapeutics Inc (NASDAQ: SRNE) is filing for...
Is a Surprise Coming for Sorrento Therapeutics (SRNEQ) This Earnings Season?
Zacks via Yahoo Finance· 1 year agoSorrento Therapeutics (SRNEQ) is seeing favorable earnings estimate revision activity and has a...
Further weakness as Sorrento Therapeutics (NASDAQ:SRNE) drops 12% this week, taking one-year losses...
Simply Wall St. via Yahoo Finance· 2 years agoSorrento Therapeutics, Inc. (NASDAQ:SRNE) shareholders should be happy to see the share price up 22%...